We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Dressing Designed to Prevent Skin Reactions During Radiation Therapy

By HospiMedica International staff writers
Posted on 25 Feb 2014
New Zealand researchers have shown that severe skin reactions during radiotherapy could be prevented by applying a thin transparent silicone dressing to the skin from the first day of treatment. More...


Although many skincare products have been assessed in clinical trials over the years, until now none has been able to completely prevent severe skin reactions, according to senior lecturer Dr. Patries Herst from the department of radiation therapy at the University of Otago Wellington (New Zealand). Dr. Herst and her team of radiation therapists, oncology nurses, and medical physicists have completed five randomized controlled clinical trials in New Zealand public hospitals in Dunedin, Wellington, Palmerston North, and Auckland Radiation Oncology over the past five years, all centering on side effects caused by radiation therapy.

Their most recent trial was a close collaboration with Dunedin Hospital, and demonstrated it is possible to prevent skin reactions from developing in breast cancer patients undergoing radiation therapy. Skin reactions are common in these patients, ranging from mild redness to ulceration with symptoms of pain, burning, and itchiness, Dr. Herst said. “This can impact negatively on day-to-day life for patients who already have to cope with being diagnosed with and treated for cancer.”

Dr. Herst is quite pleased with the results, and identification of a product that performs well. “This is fantastic news for cancer patients and it has put New Zealand firmly on the world map as a leader in clinical research into radiation-induced acute side effects.”

The dressings work by adhering closely to the small folds in the skin without the use of adhesives, so do not stick to open wounds. By protecting the radiation-damaged skin from friction against clothing items or other body regions, they allow the stem cells of the skin to heal from the radiation damage in an undisturbed setting. The dressings are also free of chemicals that could react with the skin.

Dr. Herst is currently setting up a trial that will evaluate the dressings in head and neck cancer patients. The study’s findings have been published online January 31, 2014, in the international journal Radiotherapy and Oncology.

Related Links:
University of Otago Wellington



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.